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Accumulating evidence suggests that Notch sig-
naling is active at multiple points during hematopoi-
esis. Until recently, the majority of such studies
focused on Notch signaling in lymphocyte differenti-
ation and knowledge of individual Notch receptor
roles has been limited due to a paucity of genetic
tools available. In this manuscript we generate and
describe animal models to identify and fate-map
stem and progenitor cells expressing each Notch
receptor, delineate Notch pathway activation, and
perform in vivo gain- and loss-of-function studies
dissecting Notch signaling in early hematopoiesis.
These models provide comprehensive genetic
maps of lineage-specific Notch receptor expression
and activation in hematopoietic stem and progenitor
cells. Moreover, they establish a previously unknown
role for Notch signaling in the commitment of blood
progenitors toward the erythrocytic lineage and link
Notch signaling to optimal organismal response to
stress erythropoiesis.
INTRODUCTION
Notch signaling defines a conserved, fundamental pathway
responsible for determination in metazoan development and is
widely recognized as an essential component of lineage-specific
differentiation and stem cell self-renewal in many tissues
(Artavanis-Tsakonas et al., 1995; Kopan and Ilagan, 2009),
including the hematopoietic system. Hematopoiesis is a com-
plex process that requires coordination between proliferation,
self-renewal, and differentiation of stem and progenitor cells to
generate mature blood cells (Orkin and Zon, 2008). All Notch
receptor paralogs (Notch1–4) and their ligands have been impli-
cated in the regulation of diverse functions in the hematopoietic190 Cell Stem Cell 13, 190–204, August 1, 2013 ª2013 Elsevier Inc.system. The best-described functions of Notch are in the
emergence of fetal hematopoietic stem cells (HSCs) (Clements
et al., 2011; Dzierzak and Speck, 2008; Kumano et al., 2003)
and T cell commitment and early development. Indeed, the sig-
nificance of Notch1 for T lymphocyte commitment, differentia-
tion, and oncogenic transformation has been well established
(Ciofani and Zu´n˜iga-Pflu¨cker, 2005; Grabher et al., 2006; Tani-
gaki et al., 2002). Recent studies have also suggested a function
for Notch in hematopoietic regeneration (Butler et al., 2010;
Varnum-Finney et al., 2011); however, its relevance for the self-
renewal and maintenance of adult HSCs has been questioned
(Maillard et al., 2008).
On the other hand, data regarding its involvement in nonlym-
phoid adult blood lineages is scarce and often controversial.
Recent studies suggested a role for Notch4 in megakaryocyte
(Mk) differentiation (Mercher et al., 2008), but further studies in
human hematopoietic progenitors challenged this conclusion
(Poirault-Chassac et al., 2010). Furthermore, there is little evi-
dence connecting specific Notch receptors with nonlymphoid
hematopoietic lineages. We recently reported that the condi-
tional silencing of Notch signaling in the bone marrow results in
the expansion of granulocyte-monocyte progenitors (GMPs)
and that eventually these animals develop a chronic myelo-
monocytic leukemia (CMML)-like disease (Klinakis et al., 2011),
suggesting that Notch signaling might be involved in early
stem/progenitor cell fate decisions.
To fate-map Notch receptor expression and pathway activity
in the hematopoietic system, we used tamoxifen-inducible
CreER knockin mice for individual Notch receptors in combina-
tion with a Notch reporter strain (Hes1GFP). Our lineage tracing
studies have revealed an intriguing division of labor between
Notch1 and Notch2, with the former marking mainly lymphocyte
progenitors and the latter reaching peak levels during early
erythropoiesis. Interestingly, Hes1- or Notch2-expressing pro-
genitors were enriched for erythroid potential and upregulated
the expression of an erythroid gene program. Accordingly, con-
ditional Notch gain-of-function in hematopoietic progenitors
promoted erythroid commitment and Notch loss-of-function
decreased the number of erythroid progenitors and increased
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Roles of Notch in HSC Differentiationperipheral blood platelet counts. Using a combination of genetic
fate mapping, transgenic reporters, and conditional Notch gain-/
loss-of-function, we define lineages regulated by individual
Notch receptors and reveal a role for Notch signaling in physio-
logical and stress erythropoiesis.
RESULTS
Notch Receptor In Vivo Lineage Tracing Reveals a
Division of Labor during Early Hematopoiesis
To lineage-trace Notch receptor expression in hematopoiesis,
we have used mice with the CreERT2 cassette knocked into
the endogenous loci of each of the Notch receptors. We crossed
them to the ROSA26lsl-RFP reporter strain (Luche et al., 2007)
(Figure 1A). After receiving tamoxifen and after various periods
of chase, Notch(1–4)CreER mice were analyzed, and only Notch1
and Notch2 were detectable in bone marrow progenitors. After
both 3 and 7 day chase, Notch1CreER predominantly labeled
bone marrow progenitors with lymphoid potential, including
lymphoid-primed multipotent progenitors (L-MPPs) and com-
mon lymphoid progenitors (CLPs) (Figures 1B–1D and Figures
S1A and S1B available online). In contrast, Notch2CreER-labeled
cells were found mostly in nonlymphoid progenitors, indicating
that there is lineage-specific expression of Notch receptors in
stem/progenitor cells. The peaks of Notch2 labeling were within
the HSC and pre-erythrocytic stages of differentiation. Interest-
ingly, short chase labeling experiments indicated an almost
complete absence of Notch1 labeling within all nonlymphoid
progenitor subsets, likely reflecting the lack of receptor expres-
sion of Notch1 in all such subsets. Intriguingly, even after
20 weeks of chase, there were sustained higher levels of
Notch2 labeling within the myelo-erythroid fraction (Figures
S1C and S1D).
Closer analysis of progenitor subsets in Notch2CreER mice re-
vealed that the percentage of RFP+ cells was significantly higher
in erythroid and megakaryocytic progenitors (pre-megakaryo-
cyte-erythrocytes [pre-MegEs], colony forming unit erythrocytes
[CFU-Es], andmegakaryocyte progenitors [MkPs]) than in GMPs
at both 3 and 7 days after tamoxifen injection. After a 3 day
chase, approximately 15% and 30% of pre-MegEs and CFU-
Es, respectively, were RFP+ compared to 2% in the GMP subset
(Figure 1B). This implied that expression of Notch2 could be
important in the megakaryocyte-erythrocyte (MegE) versus
granulocyte-monocyte (GM) cell fate decision at an early pro-
genitor stage. Additionally,Notch2CreER-labeled cells were found
with increasing frequency within the erythroid progenitor fraction
(up to 35%) in comparison to MkPs (<10%) (Figures 1B and 1D).
From the bipotent pre-MegE to the CFU-E erythroid progenitor,
there was a sustained increase in RFP+ cells, whereas the fre-
quency actually decreased between the pre-MegE and the
MkP at both time points. Notch3 and Notch4 labeling was not
detected in the bone marrow (Figures 1B and 1D). Notch3 label-
ing appeared in early thymic T cell progenitors and was detect-
able in mature T cells with longer periods of chase (Figure 1C
and data not shown). Notch4 labeling was extremely infrequent
throughout the hematopoietic system but was detectable in
splenic CD8+CD11c+ dendritic cells (DCs), in agreement with
previous quantitative RT-PCR data (Sekine et al., 2009) (Fig-
ure S1F). To confirm lineage tracing results at the level of tran-Cscription, we carried quantitative RT-PCR analysis for the four
Notch receptors (Figure S1E). Similar to our lineage tracing re-
sults, mainly Notch2 mRNA was detected in HSCs, with only
low levels of Notch1 mRNA. In the myelo-erythroid progenitor
compartment, Notch1 was detected at low levels in GMPs and
pre-MegEs, whereasNotch2was detected at significantly higher
levels. Only Notch2 mRNA was detected in CFU-Es and MkPs.
Consistently, no expression of Notch3 and Notch4 mRNA was
detected in these populations.
Furthermore, we were able to confirm these fate-mapping
studies using receptor-specific antibodies (Fiorini et al., 2009).
Indeed, Notch1 surface labeling increased during commitment
to the lymphocytic lineage and did not appear to be detectable
outside the lymphoid lineage. Conversely, Notch2 was not ex-
pressed in early lymphoid progenitors (Figure 1E). Expression
of Notch2 was low in CMPs and GMPs but significantly higher
in erythroid progenitors (pre-MegEs, CFU-Es, and proerythro-
blasts [ProEs]). Notch2 surface labeling reached a peak in
CFU-E progenitors and proerythroblasts but began to decrease
at the basophilic erythroblast stage (Figure 1E and data not
shown). In comparison to erythroid progenitors, MkPs ex-
pressed lower levels of surface Notch2. Whereas only a fraction
of cells from populations like HSCs were stained in the lineage
tracing experiments, most of these cells appeared to be stained
using antibodies. This discrepancy most likely reflects a partial
recombination efficiency of CreER, particularly after limited
numbers of tamoxifen injections. Consistent with the lineage
tracing results, Notch4 surface expression was detectable in a
subset of splenic DCs (Figure S1G) and undetectable in hemato-
poietic stem and progenitor cells (HSPCs) in the bone marrow
(Figure S1H), once more suggesting that Notch4 signaling plays
no role during early hematopoiesis. Our combined lineage
tracing and antibody labeling studies suggested a very tightly
regulated division of labor between the Notch1 and Notch2 re-
ceptors during early stages of hematopoiesis.
In Vivo Mapping of Notch Pathway Activation during
Early Hematopoiesis
To combine lineage tracing and receptor expression with
pathway activation, we used a reporter knockin allele (Fre
et al., 2011) in which the Hes1 locus, a well-known direct tran-
scriptional target of Notch, drives expression of GFP (Hirata
et al., 2002; Ntziachristos et al., 2012) (Figure 2A). To validate
the model, we initially characterized the thymus, where the role
ofNotch1 is well established.We found thatHes1mRNA expres-
sion was more than 50-fold higher in cells expressing Hes1GFP
and that expression of other well-characterized Notch target
genes was also increased in Hes1GFP+ cells, confirming that
Hes1-expressing cells reflected the activation of the Notch
pathway (Figure S2A). In the thymus, Hes1GFP expression was
first detected in a fraction of early T cell progenitors (ETPs)
and increased during T cell commitment up to the DN3
(CD4CD8CD25+cKitCD44) stage where Notch activation
reached its peak (Figures S2B and S2C). After this stage of differ-
entiation, Notch signaling activity is downregulated (Kleinmann
et al., 2008). Accordingly, we found that in CD4+CD8+ double
positive T cells (DPs), the expression ofHes1GFPwas also down-
regulated (Figures S2B and S2C). Consistent with this differenti-
ation and stage-specific Hes1 expression, GFP+ cells wereell Stem Cell 13, 190–204, August 1, 2013 ª2013 Elsevier Inc. 191
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Figure 1. Notch(1–4)CreER In Vivo LineageTracingSuggests aDivision of Labor betweenNotch1andNotch2during Early Adult Hematopoiesis
(A) Schematic depiction of the Notch(1–4)CreER 3 ROSA26RFP mouse strain.
(B) Analysis of RFP reporter expression 72 hrs after a single injection of tamoxifen focused at defined stem and progenitors populations. Frequency of reporter
labeling is represented as mean ± standard deviation (SD) (n = 5 for each cohort).
(C and D) Analysis of RFP reporter expression in LT-HSCs, lymphoid progenitors, and granulocyte/monocyte (G/M) and erythrocyte-megakaryocyte (Ery/Mk)
progenitor subsets 1 week after a single tamoxifen injection (n = 5). Bars denote mean ± SD.
(E) Antibody staining with APC-conjugated anti-Notch1 and PE-conjugated anti-Notch2. Notch1 expression (blue histograms) and Notch2 (red histograms) are
overlaid on isotype controls (gray filled histograms) for the same population. *p < 0.05, **p < 0.005.
HSC, Linneg/cKit+/Sca1+/Flt3/CD48/CD150+; 48DP, Linneg/cKit+/Sca1+/Flt3/CD48+/CD150+; 48SP, Linneg/cKit+/Sca1+/Flt3/CD48+/CD150; LMPP,
Linneg/cKit+/Sca1+/Flt3+/IL7ra; CLP, Linneg/cKitlo/Sca1lo/Flt3+/IL7ra+; GMP, Linneg/cKit+/Sca1/CD41/CD150/FcgRII/III+; pre-MegE, Linneg/cKit+/Sca1/
CD41/FcgRII/III/CD150+/CD105; CFU-E, Linneg/cKit+/Sca1/CD41/FcgRII/III/CD150/CD105+; MkP, Linneg/cKit+/Sca1/CD41+/CD150+; DN3, CD4/
CD8/CD44/cKit/CD25+; and pro/preB, B220+/IgM. See also Figure S1.
Cell Stem Cell
Roles of Notch in HSC Differentiation
192 Cell Stem Cell 13, 190–204, August 1, 2013 ª2013 Elsevier Inc.
Cell Stem Cell
Roles of Notch in HSC Differentiationlocated primarily in the thymic cortex (Figure S2D). These studies
validated the use of the HES1GFP mice as a faithful Notch re-
porter in the immune system. In agreement with this idea, high
levels of Hes1 expression were also found in marginal zone B
cells (MZBs), which require Notch signaling (Moriyama et al.,
2008; Tanigaki et al., 2002; data not shown).
Notch Pathway Activation Marks Initiation of
Commitment to the Erythroid Lineage
In the bone marrow, Hes1GFP expression was detected within
the LinnegcKit+ hematopoietic fraction containing stem and
progenitor cells. Interestingly, Hes1 expression was detected
within the LT-HSC fraction and was virtually undetectable at
the downstream multipotential progenitor (MPP) subsets (Fig-
ure 2B). Whole-transcriptome studies of both Hes1GFP-positive
and -negative Linneg/cKit+/Sca1+ (LSK) cells supported our
phenotypic analysis because they correlated the Hes1GFP frac-
tion to the expression of genes, characteristic of the HSC stage
(Figure S3A). Interestingly, Hes1GFP LSK cells also expressed
gene signatures correlating to erythrocytic differentiation, sug-
gesting an early molecular bias toward the erythrocytic and
against the GM/Mk lineages (Figures S3B and S3C). Further
fractionation of long-term HSCs (LT-HSCs) based on their GFP
expression showed that the observed erythroid bias seen at
the level of LSK population was also evident in this compart-
ment. Indeed, LT-HSCs expressed higher levels of key erythroid
genes such as Klf1 or Epor and lower levels of myelo/lymphoid
genes such as Sfpi1 (Figure S3D). Furthermore, when LSK GFP+
and GFP were tested for their erythroid potential in methylcel-
lulose CFU-E colony assay, LSK cells expressing Hes1 showed
greater erythroid colony forming potential (Figure S3E). In agree-
ment with this expression profiling and our aforementioned line-
age tracing experiments, which demonstrated an erythroid bias
in Notch2CreER labeling, Hes1 expression was virtually undetect-
able at the CMP and GMP subsets (Figure S2E) and significantly
derepressed at the bipotent pre-MegE stage and subsequently
increased as cells committed to the erythroid lineage, at the pre-
CFU-E and CFU-E stages (Figure 2C). The extent of Notch
activation was more pronounced in the spleen, a major site of
erythrocytic differentiation in the mouse, because high levels
of Hes1GFP were detected in erythrocytic progenitors (Figures
2D and 2E). This higher pathway activity in the spleen could
not be explained by differential surface expression of Notch2
andmost likely reflects differential ligand availability in this tissue
(data not shown). Interestingly, the activation of the Notch
pathway was transient in both tissues as it was downregulated
at later stages of erythrocytic differentiation (Figure S2F).
Hes1 expression remained low in MkPs, suggesting that Notch
is not active (or is attenuated) in early Mk development
(Figure S2G).
To directly connect Hes1GFP expression to Notch signaling we
have crossed theHes1GFPmice to animals that conditionally lack
gamma-secretase activity and thus Notch signaling (Vav1-cre
Ncstnf/f). We had previously shown that Ncstn deletion pheno-
copies Notch receptor loss and that Ncstn/ phenotypes could
be rescued totally by the expression of an activated form of
Notch (Klinakis et al., 2011). Using Vav1-cre Ncstnf/f Hes1GFP
mice, we were able to show that Notch inactivation led to an
almost complete reduction of Hes1GFP levels in erythrocyte pro-Cgenitors, suggesting direct regulation of Hes1 expression by
Notch signaling in erythrocytic progenitors (Figures 2F and 2G).
Differential Patterns ofNotchActivity betweenFetal and
Adult Hematopoiesis
Because initiation of erythropoiesis is a crucial event during fetal
hematopoiesis, we decided to study the activation of Notch
signaling and its relationship to red blood cell differentiation in
the embryo. We first looked at primitive hematopoiesis in the
yolk sac. We carried quantitative RT-PCR for each of the Notch
receptors as well as for Hes1. Yolk sac HSPCs expressed both
Notch1 andNotch2 but showed noHes1 expression, suggesting
that Notch signaling is not activated at this stage. Interestingly,
Mks and red blood cells showed only expression of Notch2
and red blood cells also expressed moderate but significant
levels of Hes1, suggesting activation of the Notch pathway (Fig-
ures S3F and S3G). We then focused on fetal liver embryonic
hematopoiesis. We probed Notch receptor expression by RT-
PCR and found mainly Notch2 expression (Figure 3A). Notch1
had low expression levels in HSCs, CMPs, and GMPs but
was not expressed in megakaryocyte/erythrocyte progenitors
(MEPs), consistent with our observation in adult stem and pro-
genitor cells. We then used the Hes1GFP reporter strain to probe
activation of the Notch pathway. Interestingly, we found that fetal
liver hematopoiesis follows a pattern of activation distinct from
what we reported in adults. At embryonic day 13.5, the majority
of the phenotypic LT-HSCs expressed significant amounts of
Hes1, but this expression was absent frommore committed pro-
genitors (Figure 3B). Hes1GFP+ HSCs were bona fide LT-HSCs
capable of long-term full lineage reconstitution of lethally irradi-
ated recipients (data not shown). Similar to sorted Hes1GFP cells
from adult mice, fetal liver HSCs expressing Hes1 were charac-
terized by a Notch transcriptional signature (Figures 3C and 3D),
as judged by transcriptome profiling and quantitative RT-PCR
studies. Interestingly, Hes1GFP-expressing fetal HSCs also re-
vealed a lymphocytic gene expression bias, in contrast to the
erythroid bias found in adult Hes1GFP-expressing HSCs (Figures
3D and 3E). Furthermore, Hes1 expression and Notch pathway
activation was undetectable in fetal erythroid progenitors, under-
lining the differences between fetal and adult hematopoiesis in
regard to Notch activation.
Hes1+ Progenitors Show Increased Erythroid Potential
and an Erythroid Transcriptional Profile
Next, we returned to adult hematopoiesis and further focused
on the connection of Notch activity to erythropoiesis. Linneg/
cKit+/Sca1 progenitors (cKit+ progenitors) were sorted based
on Hes1GFP expression and plated into methylcellulose or
collagen-based semisolid medium to be assayed for lineage
potential. Hes1 expressing cells were enriched in the erythroid
lineage potential whereas Hes1-negative mainly differentiated
into granulocytes/monocytes (GMs) or Mks (Figure 4A). FACS
analysis demonstrated Gr1+CD11b+ cells were virtually absent
in colonies generated by Hes1+ progenitors and that most cells
expressed the erythroid marker TER-119. This enhancement in
erythroid potential was supported by CFU-E assays, which
confirmed this striking difference in the presence of Hes1
expression (Figure 4B). In addition, there were fewer CD41+ cells
in colonies from Hes1+ progenitors (Figure 4A). We furtherell Stem Cell 13, 190–204, August 1, 2013 ª2013 Elsevier Inc. 193
AHes1-GFP 4pAemGFP
Hes1 locus
Targeting Vector
1 2 43
4NEOpA TkemGFP
B
LT-HSC
13
48DP
18
48SP
5811
41 15 5.4
CD48
C
D
15
0
GFP
48DP 48SPLT-HSC
C
28 31 32
GFP
CFU-EpreCFU-EpreMegE
E
85 95 100
GFP
CFU-EpreCFU-EpreMegE
Spleen
F
D
G
Bone marrow
0 102 103 104 105
0
20
40
60
80
100
%
 o
f M
ax
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
Spleen
Bone marrow
PreMegE
PreMegE
PreCFU-E
PreCFU-E
CFU-E
CFU-E
%
 o
f M
ax
GFP
GFP
0
5
10
15
20
25
30
35
40
45
0
20
40
60
80
100
120
Ncstn 
Ncstnwt/wt Hes1GFP/wt
-/- Hes1GFP/wt
%
 G
FP
+ 
ce
lls
%
 G
FP
+ 
ce
lls
PreMegE PreCFU-E CFU-E
PreMegE PreCFU-E CFU-E
CD71GFP MergedTer119 Merged
CD71GFP MergedCD45 Merged
69 4.6
1412
CFU-E
CD150
C
D
10
5
preCFU-E
preMegE
Figure 2. The Hes1GFP Reporter Identifies Points of Notch Pathway Activity
(A) Targeting strategy used to express GFP from the endogenous Hes1 promoter.
(B) Analysis of LSK stem and progenitor cells in bone marrow of Hes1GFP reporter mice.
(C and D) High-resolution separation of Linneg/cKit+/Sca1 progenitors on the basis of CD105, CD150, CD16/32 (FcgRII/III), and CD41 expression and expression
of Hes1GFP in erythroid progenitors in (C) bone marrow and (D) spleen (a representative of more than five experiments is shown).
(legend continued on next page)
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Roles of Notch in HSC Differentiationaddressed the Mk potential of cKit+ progenitors in acetylcholin-
esterase (AchE)-stained collagen-based semisolid cultures,
which is the definitive way to measure CFU-Mk potential (Jack-
son, 1973). Hes1+ cells formed significantly fewer AchE+ Mk
colonies than Hes1neg cells (Figure 4C). Furthermore, the infre-
quent CFU-Mk colonies generated by Hes1+ progenitors were
usually much smaller than CFU-Mk colonies from cells that
were Hes1neg (data not shown). The absence of a correlation
between Notch activation and promotion of the Mk lineage
further questions involvement of Notch4 signaling in this lineage
commitment as previously suggested (Mercher et al., 2008).
To analyze the transcriptional program of progenitors with an
active Notch pathway, we sorted cKit+ progenitors based on
expression level of Hes1GFP and used them for whole-transcrip-
tome analysis. Cluster analysis of microarrays from Hes1GFP
mice revealed that Hes1+ progenitors have a transcriptional pro-
file almost identical to pre-CFU-E erythroid progenitors (Pronk
et al., 2007), whereas Hes1neg progenitors clustered closely
with pre-GM and MkP populations (Figure 4D). Also, we
compiled genes important in erythroid, GM, andMk lineage-spe-
cific differentiation and found that essential erythroid and Notch
target genes were both upregulated in Hes1+ progenitors (Fig-
ure 4E). The expression of GM and Mk-specific genes was
downregulated. Changes in expression of selected genes were
verified by quantitative RT-PCR. As expected, in the Hes1GFP+
cells, Hes1 and Nrarp expression was significantly upregulated,
as was the expression of erythroid genes (Epor and Gypa) (Fig-
ure 4E and Figure S4A). The transcription factor Runx1 and the
thrombopoietin receptor Mpl are essential for generation of
normal Mks and platelets. In GFP+ progenitors, expression of
both Runx1 and Mpl was decreased compared to GFP. More-
over, the expression levels of transcription factors known to be
important in the GM lineage, such as Pu.1 (Sfpi1) and Cebpa,
were reduced in GFP+ progenitors (Figure 4E and Figure S4A).
To further compare the gene expression profiles of Hes1+ to
Hes1neg LinnegcKit+ progenitors, we used gene set enrichment
analysis (GSEA) and analyzed expression of established line-
age-affiliated gene sets by comparing the transcriptional profile
of HSCs to more committed progenitors such as LMPPs, GMPs,
and MEPs (Ng et al., 2009). Genetic signatures expressed in
early (s-ery) and more committed (d-ery) erythroid progenitors
were significantly enriched inHes1+ LinnegcKit+ cells. In contrast,
gene sets characteristic of GMand lymphoid progenitors (r-myly)
showed a negative enrichment (Figure S4B). As previously
mentioned, our microarray analysis indicated that key Mk-asso-
ciated genes were repressed in Hes1+ progenitors. Notably,
using similar gene sets (Mercher et al., 2008) we revealed an
inverse relationship between the expression of Hes1 and Mk-
related genes. Transcriptional profiling therefore supports the
notion that Hes1 expression is characteristic of progenitors
committed (or destined to commit) to the erythroid lineage.
To probe the role of Notch signaling in human erythropoiesis,
we examined public gene expression databases for expression(E) Immunofluorescence staining of spleen from Hes1GFP reporter mouse showin
(F) Representative histograms showing GFP levels in erythroid progenitors in bon
Ncstn/ Hes1wt/GFP.
(G) Bar graphs representing average percentage of GFP+ cells in displayed popu
See also Figure S2.
Cof Notch-related genes. In agreement with the results pre-
sented thus far, we found, using meta-analysis of whole-tran-
scriptome data (Novershtern et al., 2011), that Notch pathway
genes were upregulated during human erythroid differentiation
(Figure S4E). More importantly, expression of Notch direct tran-
scriptional targets (including Hes1, Hey1, Gata3, and Tcf7)
increased in human erythroid progenitors. We therefore pro-
pose that Notch activation is an evolutionarily conserved hall-
mark of erythroid differentiation not only in mice but also in
humans, suggesting that our findings may be of broader
significance.
Notch2 Signaling Commits Bipotent Pre-MegE
Progenitors to the Erythroid Lineage
The bipotent pre-MegE progenitors generate erythroid and Mk
progenitors both in vitro and in vivo (Pronk et al., 2007). To
investigate whether Notch signaling can function at this branch
point, we sorted pre-MegEs based on Hes1GFP expression and
plated cells in semisolid media. Hes1+ cells generated a sig-
nificantly higher number of pure erythroid colonies and fewer
mixed erythroid-Mk colonies or pure Mk colonies (Figure 4F).
Conversely, Hes1neg pre-MegEs developed more mixed MegE
colonies and pure Mk colonies. This suggested that in the
absence of Notch signaling, pre-MegEs retain megakaryocytic
potential. Also, in CFU-E assays, pre-MegEs that expressed
Hes1 generated more CFU-Es than the Hes1neg ones (Fig-
ure 4G). We then focused on Notch2, as it is the only Notch re-
ceptor expressed on pre-MegE progenitors and the down-
stream early erythroid precursors (Figure 1, Figure S1). In
agreement with our previous findings, pre-MegEs sorted for
surface Notch2 expression generated more CFU-E erythroid
colonies than Notch2low progenitors (Figure S4C). Finally,
GSEA of pre-MegEs, sorted based on Hes1GFP expression,
demonstrated that erythroid genes are enriched in the Hes1-ex-
pressing fraction in comparison to the GFP fraction. Analysis
of Mk transcription gene sets (Mercher et al., 2008) revealed
an inverse relationship between the expression of Hes1 and
Mk-related genes as we previously found with cKit+ progenitors
(Figure S4D).
Notch2 Gain of Function Promotes Early Erythroid
Progenitor Differentiation in Vivo
If Notch signaling activation characterizes commitment of adult
hematopoietic progenitors to the erythrocytic lineage, it is
conceivable that genetic manipulation of the pathway could pro-
mote or impede adult erythropoiesis in vivo. We thus generated
transgenic mice expressing the active domain of each Notch
receptor from the ubiquitously expressed ROSA26 promoter
(Figure 5A). Using these animals, we conditionally expressed
intracellular Notch-IC(1–4) (ICN1–4) using inducible Cre-recom-
binase strains and monitored expression of the transgene using
YFP (Ku¨hn et al., 1995; Ruzankina et al., 2007; Seibler et al.,
2003). This approach allowed us to compare the functionalg colocalization of GFP and CD71 staining in the red pulp.
e marrow (upper panel) and spleen (lower panel) of Ncstnwt/wt Hes1wt/GFP and
lations from bone marrow (upper panel) and spleen (lower panel).
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Figure 3. Differential Patterns of Notch Activity between Fetal and Adult Hematopoiesis
(A) Quantitative RT-PCR analysis of Notch receptor genes in Linneg/cKit+/Sca1+/CD48/CD150+ HSCs, Linneg/cKit+/Sca1/CD34+/FcgRII/IIIlo CMPs,
Linneg/cKit+/Sca1/CD34/FcgRII/III MEPs, Linneg/cKit+/Sca1/CD34+/FcgRII/IIIhi GMPs, and CD71+/ TER-119+ RBCs from E13.5 fetal liver. Data represent
mean ± SD of three biological replicates.
(B) Expression of Hes1GFP in fetal liver Linneg/cKit+/Sca1+ stem and multipotential progenitor populations separated into LT-HSCs (CD48/CD150+), CD48+/
CD150+ double positive cells (CD48DP), and CD48+/CD150 single positive cells (CD48SP) (upper panel) and in Linneg/cKit+/Sca1/CD41/FcgRII/III pre-
MegEs (CD150+/CD105), pre-CFU-Es (CD150+/CD105+), and CFU-Es (CD150/CD105+) (middle panel) and late erythrocyte progenitors (lower panel).
(C) Quantitative RT-PCR analysis of Notch signaling pathway target genes in Linneg/cKit+/Sca1 progenitors (MP) and Linneg/cKit+/Sca1+ (LSK) GFP+ and GFP
cells from E13.5 fetal liver. Data represent mean ± SD of three biological replicates.
(D) Gene set enrichment plots of fractionated Linneg/cKit+/Sca1+ GFP+ versus GFP from E13.5 fetal liver of Hes1GFP mice for the indicated gene sets.
(E) Heat map of lymphoid differentiation genes and Notch signaling pathway target genes expressed in Linneg/cKit+/Sca1+ GFP+ versus GFP from E13.5
fetal liver.
See also Figure S3.
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Figure 4. Hes1 Expression and Notch Activity Are Predictive of Commitment to the Erythrocytic Lineage
(A) One week after methylcellulose culture in a complete cocktail of cytokines, colonies from Hes1-expressing (right panels) and Hes1 negative Linneg/cKit+/
Sca1 progenitors (left panels) were analyzed by FACS for expression of Gr1 versus CD11b and TER-119 versus CD41. (B) CFU-E in methylcellulose supple-
mented with EPO and (C) CFU-Mk assays in collagen gel with TPO and IL-3 and sorted Linneg/cKit+/Sca1 progenitors from Hes1GFP bone marrow. (D) Hier-
archical clustering of fractionated Hes1GFP Linneg/cKit+/Sca1 progenitors with other progenitor populations. (E) Heat map of Notch target genes and key genes
expressed in the erythroid, granulocyte/monocyte (G/M), and megakaryocyte (MegaK) lineages. Bars denote standard deviation. (F) Lineage potential of sorted
pre-MegE progenitors was evaluated in complete methylcellulose 7 days after sorting. (G) CFU-E assay and (H) CFU-Mk assay of sorted pre-MegEs based on
Hes1 expression (Hes1+, dark gray bar; Hes1, light gray bar). For (B), (C), and (F–H), data are representative of average ± SD of three independent experiments.
*p < 0.05, **p < 0.005. See also Figure S4.
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Figure 5. Notch2 Gain of Function Enhances Erythroid Differentiation
(A) Generation of ROSA26-Notch(1–4)-IC mice for conditional expression of intracellular Notch and IRES-YFP driven by the ROSA26 promoter.
(B) Representative FACS plot of erythroid progenitors. CFU-E progenitors were increased in both the spleen and bone marrow upon conditional expression
of ICN2.
(legend continued on next page)
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Roles of Notch in HSC Differentiationconsequences of expressing each of the four ICNs from the
same promoter in hematopoiesis. Interestingly, although we
could demonstrate that all transgenes were expressed at com-
parable levels (Figure S5A and not shown), only expression of
ICN1was sufficient to induce T cell leukemia in vivo (Figure S5B),
suggesting that each ICN defines distinct thresholds of signaling
strength. Because Notch2 is the only receptor expressed during
early erythropoiesis, we focused our subsequent gain-of-
function studies on the effect of Notch2 activation (ICN2) in
bone marrow hematopoietic progenitors. Activation of ICN2
expression in hematopoietic cells using the polyI:polyC inducible
Mx1-Cre resulted in a significant increase of CD105+ CFU-E
erythroid progenitors and CD71+ erythroblasts in the bone
marrow and spleen (Figures 5B–5D). Platelet counts were signif-
icantly reduced in mice when ICN2 was expressed (Figure 5E
and Table S1). Histological analysis (Figure 5F) showed that a
dramatic increase in nucleated cells was apparent in the splenic
red pulp at low power, and the margins of B cell follicles
appeared to be blurred. ICN2 nucleated cells clearly displayed
themorphology of erythroid blast cells. Numerous early erythroid
progenitors and erythroblasts were abundant. In the bone
marrow, there was an increase in erythroid progenitor cells,
which was also confirmed by staining and differential counts of
bone marrow smears (data not shown). Strikingly, there was
5-fold reduction of Mks in ICN2 bone marrow (Figure 5F), in
agreement with the suggested negative role of the Notch
pathway in megakaryopoiesis.
We next sought to examine gene expression of sorted cKit+
progenitors that express activated ICN2 in vivo. As seen in
Hes1+ progenitors, ICN2-expressing progenitors upregulated
erythroid genes and suppressed GM and Mk genes (Figure 5G).
Transcriptional targets of Notch were upregulated in ICN2-ex-
pressing progenitors, confirming the ICN2 functionality. As with
Hes1-expressing cKit+ progenitors and pre-MegEs, the expres-
sion of erythroid gene sets (d-ery) was enriched, while the
expression of genes expressed in lymphoid or GM progenitors
(r-myly) was suppressed (Ng et al., 2009) (Figure 5H). To further
address the involvement of Notch in the choice between the
erythroid and Mk lineages, we imposed the expression of ICN2
in liquid cultures of cKit+ progenitors using a ROSA26CreER driver
and 4-hydroxytamoxifen (4-OHT). In the ROSA26-YFP control,
after being inducted with 4-OHT, both CD71+ erythroblasts
and Mks were generated in culture. However, induction of
ICN2 expression directed the differentiation of the progenitors
into mostly CD71+ erythroblasts and inhibited the generation of
FSChighCD41+ Mks (Figure S5C). These combined studies
further support our main hypothesis in that they demonstrated
that Notch2 gain of function enforces erythrocytic commitment
both in vitro and in vivo.(C) Representative FACS plot of erythroblasts. CD71+ erythroblasts were increas
(D) Bar graph showing absolute myelo-erythroid progenitor counts per femur (n
(E) Platelet counts from peripheral blood of WT (white bar), ICN1+ (blue bar), or I
(F) H&E-stained sections of spleen and bone marrow from control and ICN2 mice
Bone marrow megakaryocytes were counted in five bone marrow (103) high-po
*p < 0.05, **p < 0.005.
(G) Linneg/cKit+/Sca1 progenitors expressing ICN2 were sorted for gene expres
was generated.
(H) GSEA of erythroid gene signatures (d-ery) and myeloid-lymphoid genes (r-my
See also Figure S5 and Table S1.
CNotch Loss of Function Inhibits Early Erythroid
Progenitor Differentiation
To study effects of Notch loss of function, we used either dele-
tion of Notch1 and Notch2 or Nicastrin (a nonredundant part of
the g-secretase complex) to avoid putative compensatory re-
ceptor functions (Klinakis et al., 2011). We conditionally deleted
Notch signaling in adult mice using the Mx1-Cre deleter strain
and analyzed bone marrow progenitor distribution, focusing on
erythroblasts. In agreement with previous reports, no overt ane-
mia under steady-state conditions was noticed (Maillard et al.,
2008; Mancini et al., 2005). However, in the absence of Notch
signaling, we found that both the frequency and absolute
numbers of CD105+ CFU-E progenitors and CD45CD71+ eryth-
roblasts were significantly reduced in comparison to those of
control mice (Figures 6A–6C). Furthermore, CFU-E and CFU-
Mk assays using flow-purified Linneg/cKit+/Sca1 progenitors
showed a decreased ability of Notch-deficient progenitors to
generate CFU-Es and an increased ability of such to generate
CFU-Mks (Figure S6A). In contrast to the aforementioned gain-
of-function analysis using ICN2 ectopic expression, Notch loss
of function (in both Notch1/2/ and Ncstn/ mice) lead to
increased platelet counts and numbers of splenic Mks (Fig-
ure 6D, Figure S6B). Cell cycle and apoptosis analysis of
pre-MegE, pre-CFU-E, and CFU-E populations revealed no sig-
nificant differences between Ncstn/ and littermate controls
(Figures S6C and S6D), suggesting that the reduction of the
CFU-E population observed in Notch loss-of-function models
is mainly due to differentiation bias. These data are consistent
with our previous in vitro and in vivo studies, enforcing the idea
that in a subset of progenitors, Notch signaling is important for
early stages of lineage commitment and erythroid progenitor
differentiation.
Notch Signaling Is Essential for Optimal Progenitor
Responses during Stress Erythropoiesis
To further test the importance of Notch signaling for the genera-
tion of adult red blood cells (RBCs) and their progenitors, we
deleted Ncstn specifically in the hematopoietic system using
Vav1-cre+ Ncstnf/f animals and studied the response to stress
caused initially by the administration of phenylhydrazine (PHZ),
an oxidative agent able to cause severe hemolytic anemia.
Whereas no significant difference in the peripheral blood red
cell compartment was observed at steady state (Figure S6B),
Ncstn-deficient animals showed a significant delay of recovery
from stress as demonstrated by lower numbers of total RBCs
(Figure 6E) circulating in the peripheral blood. Because PHZ
mainly targets mature RBCs and we have shown that the activa-
tion of the Notch pathway is only transient and not evident in the
later stages of RBC differentiation, we focused on an additionaled in the spleen and bone marrow with ICN2.
= 4).
CN2+ (red bar) mice.
. Images are at 103 magnification with 633 magnification inset in lower right.
wered fields (HPFs) (n = 3). For (D)–(F), data are representative of mean ± SD.
sion arrays and a heat map of genes involved in lineage specific differentiation
ly) in ICN2+ versus WT littermates Linneg/cKit+/Sca1 progenitors.
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Figure 6. Notch Loss of Function Affects Early Erythroid Differentiation and Recovery from Erythroid Stress
(A) Adult mice were analyzed 1 week after three injections of polyI:polyC to induce compound deletion of Notch1 and Notch2 using the Mx1-Cre strain
(Mx1cre+Notch1/2/). The frequency of CFU-E progenitors and CD45CD71+ erythroblasts is shown.
(B and C) Absolute numbers of early erythroid progenitors in control and Notch1/2/ mice (n = 5) from (B) bone marrow and (C) spleen. Data represent
mean ± SD.
(legend continued on next page)
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Figure 7. ‘‘RoadMap’’ of Notch Signaling Pathway in Hematopoiesis
General overview of level of Notch1 receptor expression (blue gradient),
Notch2 receptor expression (red gradient), Notch signaling pathway activation
reported by Hes1GFP expression (green gradient), and known niches and
Notch ligands involved in adult hematopoiesis. LT-HSC, long-term hemato-
poietic stem cell; MPP, multipotential progenitor; CMP, common myeloid
progenitor; GMP, granulocyte-monocyte progenitor; pre-MegE, pre-mega-
karyocyte/erythrocyte progenitor; MkP, megakaryocyte progenitor; CFU-E,
colony forming unit erythrocyte; ProE, proerythroblast; LMPP, lymphocyte-
primedmultipotential progenitor; CLP, common lymphocyte progenitor; ProB,
pro B cell; FoB, follicular B cell; MzB, marginal zone B cell; ETP, Early thymic
progenitor; DN, double negative (CD48) T cell progenitor 3.
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Roles of Notch in HSC Differentiationstress stimulus. We selected sublethal ionizing radiation, which
rapidly eliminates marrow and splenic erythroid progenitors
while sparingmature peripheral RBCs (Peslak et al., 2012). Using
this stress stimulus we initially demonstrated that irradiation
significantly increased the abundance of Hes1GFP erythrocytic
progenitors (Figure 6F) in the bone marrow, a response initiated
as early as the pre-MegE stage. Interestingly, Notch2 receptor
cell surface expression was increased in pre-MegE cells in
response to stress (Figure S6D). These studies suggested an
enhanced activation of the Notch pathway in response to eryth-
rocytic stress. Most importantly, irradiation of Ncstn/ animals
revealed their profound inability to mount a response to radia-
tion-induced erythroid stress in the absence of Notch signaling.
Indeed, both early (CFU-E, pre-CFU-E, and pre-MegE) and late
(ProE, Basophilic Erythrocyte [BasoE], and Orthochromatic
Erythrocyte [OrthoE]) stages of RBC differentiation were virtually
absent in mice lacking Notch signaling (Figures 6G and 6H). On
the other hand, recovery of the pre-GM population was not
significantly altered in Ncstn/, suggesting that the defects
are specific to the erythroid lineage.(D) H&E-stained paraffin sections of spleens from control, Notch1/2/, and N
(E) Erythropoietic response to acute hemolytic anemia in control (Ncstnf/f) and Ncs
mean ± SD.
(F) Representative FACS plot (left panel) and quantification of proportion of GFP
irradiation. Data represent mean ± SD of three biological replicates.
(G and H) Representative FACS plots (G) and absolute quantification (H) of erythr
Ncstnf/f) (n = 3) littermates 4 days after sublethal 4Gy irradiation. Data represent
See also Figures S6 and S7.
CBecause Notch2 is the only Notch receptor expressed on the
surface of erythrocytic progenitors, we have also tested whether
Notch2 deficiency is sufficient to impede differentiation of
erythrocyte progenitors in response to stress. To exclude
contributions from the microenvironment, we have transplanted
Vav1-cre+Notch2f/fCD45.2+ bone marrow into irradiated con-
genic CD45.1+ recipients. As a control we have used Vav1-cre
Notch2f/fCD45.2+ bone marrow from littermate animals. Five
weeks posttransplant and after we verified that recipient animal
bone marrow comprised more than 90% of Notch2neg donor
cells (Figures S7A and S7B), we sublethaly irradiated the animals
and analyzed erythrocytic stress response as previously
described. Four days postirradiation Vav1-cre+Notch2f/f recon-
stituted animals showed signs of defective stress response,
including smaller spleens and significantly decreased numbers
of pre-CFU-E and CFU-E progenitors (Figures S7C–S7E) in the
spleen. On the other hand there were no significant differences
in the recovery of GM andMk progenitors, suggesting specificity
for the erythrocytic lineage. All these studies highlight the impor-
tance of Notch signaling, and specifically Notch2, in stress
erythropoiesis.
DISCUSSION
Our lineage tracing experiments provide a window into the
mechanisms utilized by distinct Notch receptors in adult and
fetal hematopoiesis. They offer in vivo mapping of receptor
expression and activity in the bone marrow and extramedullary
sites (Figure 7). Indeed, they identify a remarkable division of
labor between Notch receptors, connecting Notch1 expression
to commitment to the lymphoid lineage and Notch2 expression
to the initiation of erythrocytic differentiation. On the other
hand, Notch3 and Notch4 were not associated with bone
marrow stem/progenitor cells. Although CreER-mediated target
loci deletion is expression level dependent and recombination
may not occur at low levels of gene expression, our studies
strongly suggest thatNotch1 andNotch2 are themain regulators
of early adult hematopoiesis. In agreement with this notion and
our lineage tracing findings, antibody staining for Notch1 and
Notch2 in progenitors further confirmed our genetic fate map-
ping. Furthermore, quantitative RT-PCR analysis and antibody
staining for Notch4 confirmed the results obtained with the line-
age tracing, beacuse mRNA and cell surface expression of this
receptor were undetectable in all bone marrow stem and pro-
genitor subsets. Finally, in vivo reporter activity together with
loss- and gain-of-function genetic studies demonstrated the
crucial role for Notch signaling in early stages of hematopoietic
differentiation and stress erythropoiesis. This demonstrates the
role of Notch in RBC differentiation in vivo. It is noteworthy that
meta-analysis of human progenitor gene expression data sets
demonstrated that Notch activity is also increased when humancstn/ mice. Megakaryocytes are indicated with black arrows.
tn/ (Vav1-cre Ncstnf/f +) (n = 5) after PHZ-induced hemolysis. Data represent
+ cells in Hes1GFP/wt mice before (blue) and 4 days after (green) sublethal 4Gy
oid progenitors from bone marrow of control (Ncstnf/f) and Ncstn/ (Vav1-cre+
mean ± SD. *p < 0.05, **p < 0.005, ***p < 0.001.
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gesting that the involvement of Notch signaling during erythro-
poiesis is evolutionary conserved. Finally, we were able to
show that Notch-dependent regulation of erythropoiesis occurs
only in adult hematopoiesis and is crucial for efficient recovery
from erythrocytic stress and life-threatening anemia induced
by exposure to ionizing irradiation or blood loss.
Our studies also provide insights into the role of Notch
signaling in the differentiation of adult HSCs. We were able to
clearly identify Notch receptors that are expressed on LT-
HSCs, mainly Notch2, and show that the transcriptional target
Hes1 is activated in a subset of HSCs under homeostatic condi-
tions. Purification and subsequent serial transplantations of
Notch2RFP+ and Hes1GFP+ LSKs demonstrated that they contain
bona fide HSCs (not shown). In agreement with this notion, anal-
ysis of sorted Hes1GFP+ LSKs reveals molecular correlation to
HSC gene expression signatures. However, we were also able
to show that Hes1GFP+ LSK cells have a molecular priming
toward the erythrocytic lineage using in vitro assays and tran-
scriptome analysis. This differentiation bias toward the erythro-
cytic lineage becomes even more apparent at subsequent
stages of differentiation: multipotent LinnegcKit+ or bipotent
pre-MegE progenitors expressing Hes1GFP have a propensity
to differentiate into erythrocytes and are characterized by eryth-
rocytic gene signatures. On the other hand, without Notch
activation, progenitors (Hes1GFP negative) mainly differentiate
toward the GM or Mk lineages. There are significant conse-
quences of these findings, because they suggest that Notch
signaling could have distinct roles in different blood lineages.
In agreement with this notion, it was shown that Notch could
turn from an oncogene (T cell leukemia, B cell lymphoma)
(Grabher et al., 2006; Puente et al., 2011) to a tumor suppressor
(myelo-monocytic leukemia) (Klinakis et al., 2011) depending on
the type of hematopoietic progenitor initiating each disease. Our
current studieswould suggest that in addition to Notch inhibition,
receptor-specific pathway agonism could also be a promising
therapeutic alternative in tumors characterized by silencing of
the pathway (Lobry et al., 2011, 2013).
It would be intriguing to integrate our findings with previously
published reports on Notch function in early hematopoiesis.
The discovery of a role for Notch signaling in erythrocytic differ-
entiation and stress response could open clinically important
areas of future investigation. We clearly show that Notch
signaling suppresses Mk differentiation, which is in agreement
with its role in the promotion of erythropoiesis but is inconsistent
with a previous report suggesting that Notch4 can promote dif-
ferentiation toward this lineage (Mercher et al., 2008). However,
those studies were based largely on in vitro cultures performed in
the presence of transfected Notch ligands and exogenous
Thrombopoietin. Nevertheless, our findings are in agreement
with a recent in vitro study focusing on human hematopoiesis
and suggesting a negative role for the Notch pathway in mega-
karyopoiesis (Poirault-Chassac et al., 2010). Although it is diffi-
cult to reconcile all these studies, it is possible that they are all
correct, because at different stages of differentiation Notch
signaling could have distinct effects on MEP commitment/main-
tenance or even mature Mk differentiation and maturation.
Our data also suggest the existence of progenitor cell niches
characterized by Notch ligand expression (Figure 7) responsible202 Cell Stem Cell 13, 190–204, August 1, 2013 ª2013 Elsevier Inc.for commitment to distinct cell fates. Indeed, our work suggests
that in the bone marrow there are distinct Notch ligand-express-
ing niches, responsible for HSC function as well as lymphocytic
and erythrocytic differentiation. Although it would be intriguing to
correlate Notch signaling to specific ligand microenvironments,
development of in vivo genetic reporters in combination with
advanced imaging is required to further characterize and analyze
specific ligand expression and role. Furthermore, our finding that
activation of Notch2-mediated signaling stimulates erythroid dif-
ferentiation and is essential in the response to erythrocytic stress
could also be clinically important. Anemia is a common feature of
patients with renal disease and chronic heart failure and occurs
in the majority of cancer patients (Melnikova, 2006). Currently,
recombinant EPO is used to treat anemia and provides signifi-
cant clinical benefit (Eschbach et al., 1987). However, resistance
to EPO treatment or an insufficiency of erythroid progenitors is
found in many patients (van der Putten et al., 2008). It is possible
that such patients will benefit from simultaneous activation of
Notch2 and EPO receptors. Bioavailable peptide ligands or spe-
cific Notch2 receptor agonists could thus be important in such
clinical settings.
EXPERIMENTAL PROCEDURES
Animals
Notch(1–4)CreER andHes1GFP knockin mice were recently described (Fre et al.,
2011). ROSA26ICN(1–4) mice were generated by inserting a loxP flanked splice
acceptor NEO-ATG cassette with two polyA sites followed by ICN(1–4)-IRES-
YFP into the ROSA26 locus, allowing the ROSA26 promoter to drive expres-
sion of the NEO-ATG cassette. Cre-recombinase-mediated excision of
NEO-ATG results in use of the splice acceptor in the ICN(1–4)-IRES-YFP
cassette and irreversible expression of the transgene, and the IRES-YFP
bicistronic mRNA allows expression to be monitored by YFP expression.
ROSA26lslRFP mice (gift from H.-J. Fehling, Ulm University) and ROSA26lslYFP
animals (gift from D. Littman, NYU School of Medicine) have been described
(Luche et al., 2007; Srinivas et al., 2001). Inducible Cre animals used include
the following: the tamoxifen inducible human ubiquitin C promoter driven
CreER (Ubc-CreER) (Ruzankina et al., 2007) (gift from D. Littman, NYU
School of Medicine), tamoxifen inducible ROSA26CreER (Seibler et al., 2003)
(gift from D. Littman, NYU School of Medicine), and polyI:polyC inducible
Mx1-Cre (Jackson Labs). Notch1f/f Notch2f/f and Ncstnf/fmice were previously
described (Klinakis et al., 2011). Hematopoietic specifique Vav1-cre was pre-
viously described (Stadtfeld and Graf, 2005). All animal experiments were
done in accordance with the guidelines of the NYU School of Medicine Institu-
tional Animal Care and Use Committee.
Notch Lineage Tracing and LSK Transplants
Tamoxifen (Sigma Aldrich) was solubilized in corn oil (Sigma Aldrich) at a con-
centration of 20 mg/ml and injected intraperitoneally at 0.2 mg/g body weight.
Following (1 or 3) daily injections and a 3 day, 7 day, or 20 week chase, animals
were euthanized for analysis of peripheral blood and tissues by FACS. For
transplantation of RFP-labeled LSK cells, ROSA26CreER, Notch1CreER, and
Notch2CreER lineage tracer mice were crossed to ROSA26lslRFP reporter mice
and injected with tamoxifen daily for 3 days (0.2 mg/g mouse). Two days after
the last injection, bone marrow was isolated from femurs and tibias. Lineage-
depleted cells were stained as described, RFP+ LSK cells were sorted, and
500–750 cells were transplanted with 2.5 3 105 helper bone marrow cells
into lethally irradiated recipients. Peripheral blood was analyzed 4 weeks
and 24 weeks posttransplant.
Stress Erythropoiesis
PHZ was dissolved in PBS and injected intraperitoneally at 50 mg/kg on two
consecutive days to induce acute anemia. Peripheral blood (50 ml) was
collected and analyzed using the Hemavet 950 (Drew Scientific) hematology
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Roles of Notch in HSC Differentiationsystem. Sublethal total body irradiation of 4 Gy radiation was used to model
endogenous stress erythropoiesis as previously described (Peslak et al.,
2012). Progenitor responses were analyzed at day 4 following sublethal
irradiation.
Antibodies and Flow Cytometry
Freshly dissected femurs and tibias were dissected and bone marrow was
flushed with a 3 cm3 syringe and 25G needle into PBS with 3% FBS. The
bonemarrow suspension was centrifuged at 400 rcf for 10min at 4C, washed,
and resuspended in PBS with 3% FBS. Antibody staining and FACS analysis
was performed as previously described (Klinakis et al., 2011). All antibodies
were purchased from BD-PharMingen or e-Bioscience. We used the following
fluorochrome or biotin conjugated antibodies: CD117 (2B8), Sca-1 (D7),
CD11b (M1/70), Gr-1 (RB6-8C5), NK1.1 (PK136), TER-119, CD3 (145-2C11),
CD19 (1D3), CD21 (7E9), CD23 (B3B4), CD127 (A7R34), CD34 (RAM34),
FcgRII/III (2.4G2 or 93), CD135 (A2F10.1), CD4 (RM4-5), CD8 (53-6.7),
CD150 (9D1), CD41 (MWReg30), B220 (RA3-6B2), CD48 (HM481), CD105
(MJ7/18), F4/80 (BM8), and CD71 (Rl7217). Bone marrow lineage antibody
cocktail included CD11b, Gr-1, NK1.1, TER-119, CD4, CD8, CD3, B220, and
Il7Ra. For analysis of erythroid progenitors, TER-119 was not included in
lineage cocktail as previously described (Pronk et al., 2007).
Microarray and GSEA
Human hematopoietic population microarray data have been previously
described (Novershtern et al., 2011) and are available at the GEO database
(http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE24759.
Data were normalized using the Robust Multi-array Average algorithm using
Genespring GX software (Agilent) and gene expressions were leveled accord-
ing to GAPDH expression. Mouse erythoid and myeloid progenitor population
microarrays have been previously described (Pronk et al., 2007) and are avail-
able at GEO database under accession number GSE8407.
Microarray analysis was performed as previously described (Klinakis et al.,
2011). For each experiment, freshly isolated cells from three individual
mice were sorted by surface marker expression and GFP expression and
total RNA was extracted using the RNeasy Plus Micro kit (QIAGEN). The
Ovation RNA Amplification System V2 or Ovation Pico amplification
(NuGEN) kits were used for amplification. Amplified RNA was labeled and
hybridized to the Mouse 430.2 microarrays (Affymetrix). The Affymetrix
gene expression profiling data were normalized using the previously pub-
lished robust multiarray average algorithm using the GeneSpring GX soft-
ware (Agilent). The gene-expression intensity presentations were generated
with Multi Experiment Viewer software (http://www.tm4.org/mev/). GSEA
was performed using GSEA software (http://www.broadinstitute.org/gsea)
using gene set as permutation type, 1,000 permutations, and log2 ratio of
classes as metric for ranking genes. Gene sets used in this study have
been previously published (Mercher et al., 2008; Ng et al., 2009; Pronk
et al., 2007).
In Vitro Differentiation Assays
Sorted LSKs, Linneg/cKit+/Sca1 progenitors (500), or pre-MegEs (500) were
plated in triplicate into cytokine-supplemented methylcellulose medium
(MethoCult 3434, Stem Cell Technologies). Colonies were scored after
10 days of culture and cells were collected for analysis by FACS. For CFU-E
assays cells were plated in methylcellulose medium supplemented with EPO
(MethoCult 3334, Stem Cell Technologies) and colonies were counted
2 days after plating. Collagen gel assays for CFU-Mks were performed using
Megacult-C (supplemented TPO and IL-3, Peprotech). Collagen gels were
acetone fixed and AchE staining was performed according to the manufac-
turer’s guidelines (MegaCult-C, Stem Cell Technologies).
Statistical Analysis
The means of each data set were analyzed using Student’s t test with a two-
tailed distribution and assuming equal sample variance.
ACCESSION NUMBERS
Newly generated microarray data are available at GEO database under acces-
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